177Lu-FAP-2286 in patients with advanced or metastatic solid tumors: Initial data from a phase 1/2 study investigating safety, pharmacokinetics, dosimetry, and preliminary antitumor activity (LuMIERE)

被引：0

作者：

McConathy, Jonathan ^{[1
]}

Dhawan, Mallika ^{[2
]}

Goenka, Ajit ^{[3
]}

Moy, Ryan ^{[4
]}

Menda, Yusuf ^{[5
]}

Chasen, Beth ^{[6
]}

Khushman, Moh'd

Mintz, Akiva ^{[7
]}

Zakharia, Yousef

Sunderland, John ^{[5
]}

Bowles, Owen ^{[8
]}

Xiao, Jim ^{[8
]}

Simmons, Andrew ^{[8
]}

Wride, Kenton ^{[8
]}

Enke, Aaron ^{[8
]}

Hope, Thomas ^{[9
]}

机构：

[1] Univ Birmingham, Birmingham, AL USA

[2] Univ Calif Irvine, Irvine, CA USA

[3] Mayo Clin, Rochester, MN USA

[4] Columbia Univ, Irving Med Ctr, New York, NY USA

[5] Univ Iowa, Iowa City, IA 52242 USA

[6] MD Anderson Canc Ctr, Houston, TX USA

[7] Columbia Univ, Med Ctr, New York, NY 10027 USA

[8] Clovis Oncol Inc, Boulder, CO USA

[9] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

2271

引用

页数：2